ITMI20020514A1 - Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi - Google Patents

Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi

Info

Publication number
ITMI20020514A1
ITMI20020514A1 IT2002MI000514A ITMI20020514A ITMI20020514A1 IT MI20020514 A1 ITMI20020514 A1 IT MI20020514A1 IT 2002MI000514 A IT2002MI000514 A IT 2002MI000514A IT MI20020514 A ITMI20020514 A IT MI20020514A IT MI20020514 A1 ITMI20020514 A1 IT MI20020514A1
Authority
IT
Italy
Prior art keywords
release
tablet
constituted
active ingredient
controlled release
Prior art date
Application number
IT2002MI000514A
Other languages
English (en)
Italian (it)
Inventor
Lauretta Maggi
Ubaldo Conte
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Priority to IT2002MI000514A priority Critical patent/ITMI20020514A1/it
Publication of ITMI20020514A0 publication Critical patent/ITMI20020514A0/it
Priority to AU2003239789A priority patent/AU2003239789A1/en
Priority to ES03732266T priority patent/ES2339438T3/es
Priority to DE60330949T priority patent/DE60330949D1/de
Priority to EP03732266A priority patent/EP1482915B1/en
Priority to CNB038094851A priority patent/CN100528146C/zh
Priority to CA2478406A priority patent/CA2478406C/en
Priority to AT03732266T priority patent/ATE454887T1/de
Priority to DK03732266.6T priority patent/DK1482915T3/da
Priority to PCT/EP2003/002536 priority patent/WO2003075897A1/en
Priority to US10/507,344 priority patent/US20050095295A1/en
Priority to JP2003574172A priority patent/JP4664595B2/ja
Publication of ITMI20020514A1 publication Critical patent/ITMI20020514A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2002MI000514A 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi ITMI20020514A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
JP2003574172A JP4664595B2 (ja) 2002-03-12 2003-03-12 活性成分の放出を制御する治療システム
EP03732266A EP1482915B1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
ES03732266T ES2339438T3 (es) 2002-03-12 2003-03-12 Sistema terapeutico para la liberacion controlada de ingredientes activos.
DE60330949T DE60330949D1 (de) 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
AU2003239789A AU2003239789A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
CNB038094851A CN100528146C (zh) 2002-03-12 2003-03-12 控制活性成分释放的治疗系统
CA2478406A CA2478406C (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
AT03732266T ATE454887T1 (de) 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
DK03732266.6T DK1482915T3 (da) 2002-03-12 2003-03-12 Terapeutisk system til kontrolleret frigørelse af aktive ingredienser
PCT/EP2003/002536 WO2003075897A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
US10/507,344 US20050095295A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi

Publications (2)

Publication Number Publication Date
ITMI20020514A0 ITMI20020514A0 (it) 2002-03-12
ITMI20020514A1 true ITMI20020514A1 (it) 2003-09-12

Family

ID=11449490

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi

Country Status (12)

Country Link
US (1) US20050095295A1 (https=)
EP (1) EP1482915B1 (https=)
JP (1) JP4664595B2 (https=)
CN (1) CN100528146C (https=)
AT (1) ATE454887T1 (https=)
AU (1) AU2003239789A1 (https=)
CA (1) CA2478406C (https=)
DE (1) DE60330949D1 (https=)
DK (1) DK1482915T3 (https=)
ES (1) ES2339438T3 (https=)
IT (1) ITMI20020514A1 (https=)
WO (1) WO2003075897A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
KR101164881B1 (ko) * 2003-09-19 2012-07-23 썬 파마슈티컬 인더스트리스 리미티드 경구용 약물 전달 시스템
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
CA2607272A1 (en) * 2005-05-09 2006-11-16 Azur Pharma Limited Formulations of mast cell stabilizing agents for delivery to the colon
NZ563846A (en) * 2005-06-03 2010-03-26 Egalet As A drug delivery system for delivering active substances dispersed in a dispersion medium
US8231902B2 (en) * 2005-11-18 2012-07-31 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
MX2008016349A (es) * 2006-06-19 2009-01-28 Accu Break Technologies Inc Formas segmentadas de dosificacion farmaceutica.
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CN102026628A (zh) * 2008-02-15 2011-04-20 太阳医药高级研发有限公司 具有降低崩裂效果的口服控释片剂
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
CA2751627A1 (en) 2009-02-06 2010-08-12 Egalet Ltd. Pharmaceutical compositions resistant to abuse
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
US9622979B2 (en) * 2011-06-29 2017-04-18 Sun Pharmaceutical Industries Limited Multilayered dosage form
AU2013285988A1 (en) 2012-07-06 2015-02-12 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
WO2017136617A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
CA3023278C (en) * 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
EA201992116A1 (ru) 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи Фармацевтические составы флороглюцинола и триметилфлороглюцинола
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
JP7034343B2 (ja) * 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
WO2020027927A1 (en) * 2018-07-30 2020-02-06 Insta Therapeutics, Inc. Sublingual diltiazem and methods of use
CN113274363B (zh) * 2021-04-29 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
CN2213539Y (zh) * 1994-04-29 1995-11-29 天津市激光技术研究所 包衣上带有小孔的缓释药片
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento

Also Published As

Publication number Publication date
WO2003075897A1 (en) 2003-09-18
CA2478406C (en) 2011-02-08
JP2005526757A (ja) 2005-09-08
CN1649571A (zh) 2005-08-03
AU2003239789A1 (en) 2003-09-22
CA2478406A1 (en) 2003-09-18
JP4664595B2 (ja) 2011-04-06
US20050095295A1 (en) 2005-05-05
ES2339438T3 (es) 2010-05-20
EP1482915B1 (en) 2010-01-13
ATE454887T1 (de) 2010-01-15
DK1482915T3 (da) 2010-04-19
EP1482915A1 (en) 2004-12-08
CN100528146C (zh) 2009-08-19
ITMI20020514A0 (it) 2002-03-12
DE60330949D1 (de) 2010-03-04

Similar Documents

Publication Publication Date Title
ITMI20020514A1 (it) Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
JP2005526757A5 (https=)
DE69001831D1 (de) Wirkstoffabgabevorrichtung.
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
JP3784409B2 (ja) ディスペンサに送出ポートを形成するための方法及び装置
DE19717023A1 (de) Vorrichtung zum Behandeln von malignen, tumorösen Gewebebereichen
DE602004006497D1 (de) Wasserlösliches abgabeprodukt
DE60206078D1 (de) Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes
PT1140012E (pt) Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
BR9506029A (pt) Forma farmaêutica oral de múltipla dosagem unitária em tablete processo para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem para o tratamento de doenças inflamatórias gastrointestinais em maniferos e no homem e embalgem de ampola de pressão transversal
ES2033572A1 (es) Saquitos solubles.
DE60016920D1 (de) Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt
AR034517A1 (es) Formulacion farmaceutica
AR036838A1 (es) Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.
DE69904954D1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
DE58902457D1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
ES2256329T3 (es) Proceso par ala preparacion de un dispositivo de administracion oral.
WO2013019930A2 (en) Decomposable apparatus and methods for fabricating same
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
BRPI0812332A2 (pt) Embalagem para produtos de tabaco, e, método para fabricar a mesma
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
CY1106159T1 (el) Φαρμακευτικη συνθεση που πepιλαμβανει πενιχρα υδατοδιαλυτη σταυροσπορινη, επιφανειοδραστικη ουσια και υδατοδιαλυτο πολυμepες
PT1079867E (pt) Metodo de fabrico de um componente em po de um adesivo para utilizacao medica, utilizacao do referido componente em po e o referido componente em po
WO2003075894A8 (en) A system for the controlled release of active ingredients